Entera Bio announced that new comparative pharmacological data for its investigational agent EB613 vs. Forteo(R) was selected for presentation at the American Society for Bone and Mineral Research, ASBMR, 2024 Annual Meeting which will be held on September 27-30, 2024 in Toronto, ON, Canada.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTX: